Sep 17, 2015 7:00am EDT U.S. Food and Drug Administration Grants Fast Track Designation to Can-Fite's CF102 in the Treatment of Liver Cancer
Sep 01, 2015 7:00am EDT Can-Fite to Present at Rodman & Renshaw 17th Annual Global Investment Conference on September 9, 2015
Jul 29, 2015 7:00am EDT World Health Organization Accepted "Piclidenoson" as Proposed New Generic Name for Can-Fite's Lead Drug Candidate CF101
Jul 23, 2015 7:00am EDT Can-Fite Joins Israeli Life Sciences Delegation to Japan on July 28 - 30, 2015
Jun 29, 2015 7:00am EDT Can-Fite's CF602 Sexual Dysfunction Drug Backed by New Preclinical Data Progresses Towards an IND
Jun 19, 2015 7:00am EDT Can-Fite Subsidiary OphthaliX Signs Definitive Agreement to Acquire Improved Vision Systems Ltd.
Jun 15, 2015 7:00am EDT Can-Fite to Exhibit at Bio International Convention in Philadelphia on June 15 - 18, 2015
Jun 10, 2015 7:00am EDT Can-Fite Granted Notice of Allowance for Patent Covering Manufacturing Process of CF101 in the U.S.
